TP53 and cervical carcinoma: Glucocorticoids can also affect the life cycle of HPV, interfere with the function of p53, and reduce the expression of miR-145, thus playing direct roles in the persistence of HPV infection and resistance to chemotherapy in cervical cancer patients (Feng et al., 2012; Shi et al., 2012) (Figure 3B).